Last update :
16/06/2024
Antibiotic   Moxifloxacin  
Injection
Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Actira Luxembourg, Netherlands, Spain, Sweden
Avalox Argentina, Australia, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Ecuador, Finland, Germany, Hungary, Ireland, Malaysia, Mexico, Morocco, Netherlands, New Zealand, Peru, Romania, Saudi Arabia, Sweden, Turkey, United Arab Emirates, United States of America, Venezuela
Axokine Venezuela
Mahaflox India
Mofelox Turkey
Mofinacin Romania
Moflaxa Romania
Moksefen Turkey
Moksilox Turkey
Moxacin Turkey
Moxifix Turkey
Moxifloxin Belgium, Germany
Moxifloxina Romania
Moxifloxino Chile, Spain
Muzdil Spain
Octegra Netherlands, Sweden
Pixiriv Mexico
Praiva Ecuador, Peru
Proflox Luxembourg
Stability in solutions   Injection   Stability in solutions : Moxifloxacin     
Container Solvent Concentration Temperature Storage Duration of stability References
Polyvinyl chloride  Dianéal® PD1 1.36% glucose (Baxter) 0.025 mg/ml 25°C Not specified
7 Day
2145
Level of evidence D

Polyvinyl chloride  Dianéal® PD1 1.36% glucose (Baxter) 0.025 mg/ml 37°C Not specified
3 Day
2145
Level of evidence D

Polyvinyl chloride  Dianéal® PD1 1.36% glucose (Baxter) 0.025 mg/ml 4°C Not specified
14 Day
2145
Level of evidence D

Polyvinyl chloride Dianéal® PD1 3.86% glucose (Baxter) 0.025 mg/ml 25°C Not specified
3 Day
2145
Level of evidence D

Polyvinyl chloride Dianéal® PD1 3.86% glucose (Baxter) 0.025 mg/ml 37°C Not specified
12 Hour
2145
Level of evidence D

Polyvinyl chloride Dianéal® PD1 3.86% glucose (Baxter) 0.025 mg/ml 4°C Not specified
14 Day
2145
Level of evidence D

Not specified Glucose 5% 1,6 mg/ml 22-23°C Protect from light
24 Hour
4758
Level of evidence B


  Mentions Légales